ALT - Altimmune Inc Stock Price, Fair Value and News
7.15USD-0.21 (-2.85%)Delayed as of 07 May 2024, 03:30 pm ET
Latest Insider Trading transactions for ALT
| Datesorted ascending | Name | Buy/Sell | $ Value | # Shares | Avg. Price | Title |
|---|---|---|---|---|---|---|
| 2024-02-02 | Premium | acquired | Premium | Premium | Premium | Chief Scientific Officer |
| 2024-02-02 | Premium | acquired | Premium | Premium | Premium | President and CEO |
| 2024-02-02 | Premium | sold (taxes) | Premium | Premium | Premium | President and CEO |
| 2024-02-02 | Premium | sold (taxes) | Premium | Premium | Premium | Chief Scientific Officer |
| 2024-02-02 | Premium | sold (taxes) | Premium | Premium | Premium | Chief Medical Officer |
| 2024-02-02 | Premium | acquired | Premium | Premium | Premium | Chief Medical Officer |
| 2024-02-01 | Premium | acquired | Premium | Premium | Premium | President and CEO |
| 2024-02-01 | Premium | sold (taxes) | Premium | Premium | Premium | Chief Scientific Officer |
| 2024-02-01 | Premium | acquired | Premium | Premium | Premium | Chief Scientific Officer |
| 2024-02-01 | Premium | sold (taxes) | Premium | Premium | Premium | President and CEO |
| 2024-02-01 | Premium | acquired | Premium | Premium | Premium | Chief Medical Officer |
| 2024-02-01 | Premium | sold (taxes) | Premium | Premium | Premium | Chief Medical Officer |
| 2024-01-31 | Premium | acquired | Premium | Premium | Premium | Chief Scientific Officer |
| 2024-01-31 | Premium | acquired | Premium | Premium | Premium | Chief Medical Officer |
| 2024-01-31 | Premium | acquired | Premium | Premium | Premium | Chief Business Officer |
| 2024-01-31 | Premium | acquired | Premium | Premium | Premium | Chief Financial Officer |
| 2024-01-31 | Premium | acquired | Premium | Premium | Premium | President and CEO |
| 2024-01-30 | Premium | sold (taxes) | Premium | Premium | Premium | President and CEO |
| 2024-01-30 | Premium | acquired | Premium | Premium | Premium | Chief Medical Officer |
| 2024-01-30 | Premium | acquired | Premium | Premium | Premium | Chief Financial Officer |
| 2024-01-30 | Premium | sold (taxes) | Premium | Premium | Premium | Chief Medical Officer |
| 2024-01-30 | Premium | acquired | Premium | Premium | Premium | President and CEO |
| 2024-01-30 | Premium | acquired | Premium | Premium | Premium | Chief Scientific Officer |
| 2024-01-30 | Premium | sold (taxes) | Premium | Premium | Premium | Chief Financial Officer |
| 2024-01-30 | Premium | sold (taxes) | Premium | Premium | Premium | Chief Scientific Officer |